The MAPK/ERK signaling pathway is one more crucial target for inhibitors. This pathway is involved in controling cell survival, growth, and distinction. Inhibitors targeting MAPK/ERK are employed in cancer cells treatments to stop uncontrolled cell proliferation and lump growth. JAK/STAT signaling inhibitors modulate immune actions and are used in